A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of YZJ-1139 in Healthy Participants

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
Primary Objective: 1. To evaluate the tolerability, safety of single and multiple doses of YZJ-1139 in healthy participants 2. To evaluate the pharmacokinetic of single and multiple doses of YZJ-1139 in healthy participants Secondary objectives: To explore the safe tolerated dose of YZJ-1139, provide data support for the design of phase II dosing regimen
Epistemonikos ID: 374efc8977fc5f6c019e096694b36cf0881e835e
First added on: Dec 01, 2024